Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma von Abeykoon, Jithma P., Vaxman, Julia, Patel, Sanjay V., Kumar, Shaji, Malave, Gabriella C., Young, Kimberly S., Ailawadhi, Sikander, Larsen, Jeremy T., Dispenzieri, Angela, Muchtar, Eli, Gonsalves, Wilson I., Kourelis, Taxiarchis, Leung, Nelson, Warsame, Rahma, Go, Ronald S., Bergsagel, Leif, Lacy, Martha Q., Rajkumar, S. Vincent, Gertz, Morie A., Kapoor, Prashant

Volltext

Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma von Kumar, Shaji K., Kapoor, Prashant, Laplant, Betsy, Phuong-Dung, Liang, Muchtar, Eli, Buadi, Francis K., Gonsalves, Wilson I, Malave, Gabriella C, Vossen, Alanna M., Dingli, David, Go, Ronald S., Warsame, Rahma M, Kourelis, Taxiarchis, Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Lust, John A., Lacy, Martha Q., Dispenzieri, Angela, Hayman, Suzanne R., Leung, Nelson, Rajkumar, S. Vincent, Gertz, Morie A.

Volltext

Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma von Kapoor, Prashant, Gertz, Morie A., Laplant, Betsy, Malave, Gabriella C, Wolfe, Eric, Muchtar, Eli, Siddiqui, Mustaqeem A., Gonsalves, Wilson I, Emanuel, Angie R., Kourelis, Taxiarchis, Warsame, Rahma, Dingli, David, Buadi, Francis K., Hayman, Suzanne R., Leung, Nelson, Hwa, Yi L., Hobbs, Miriam A., Fonder, Amie, Dispenzieri, Angela, Lacy, Martha Q., Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext

Determinants of Clinical Trial Participation and Impact on Survival Outcomes Among Patients with Newly Diagnosed Multiple Myeloma von Malave, Gabriella C, Kapoor, Prashant, Dispenzieri, Angela, Gertz, Morie A., Lacy, Martha Q., Hayman, Suzanne R., Dingli, David, Buadi, Francis K., Muchtar, Eli, Gonsalves, Wilson I, Leung, Nelson, Go, Ronald S., Siddiqui, Mustaqeem, Kourelis, Taxiarchis, Warsame, Rahma M, Lin, Yi, Russell, Stephen J, Hwa, Yi L., Hobbs, Miriam A., Fonder, Amie, Rajkumar, S. Vincent, Kumar, Shaji K.

Volltext